247 related articles for article (PubMed ID: 31114322)
1. microRNA-944 inhibits the malignancy of hepatocellular carcinoma by directly targeting IGF-1R and deactivating the PI3K/Akt signaling pathway.
Lv L; Wang X; Ma T
Cancer Manag Res; 2019; 11():2531-2543. PubMed ID: 31114322
[No Abstract] [Full Text] [Related]
2. microRNA-548b suppresses aggressive phenotypes of hepatocellular carcinoma by directly targeting high-mobility group box 1 mRNA.
Yun Z; Meng F; Jiang P; Yue M; Li S
Cancer Manag Res; 2019; 11():5821-5834. PubMed ID: 31417317
[No Abstract] [Full Text] [Related]
3. microRNA-532 suppresses the PI3K/Akt signaling pathway to inhibit colorectal cancer progression by directly targeting IGF-1R.
Song Y; Zhao Y; Ding X; Wang X
Am J Cancer Res; 2018; 8(3):435-449. PubMed ID: 29636999
[TBL] [Abstract][Full Text] [Related]
4. Long non-coding RNA deleted in lymphocytic leukaemia 1 promotes hepatocellular carcinoma progression by sponging miR-133a to regulate IGF-1R expression.
Zhang W; Liu S; Liu K; Liu Y
J Cell Mol Med; 2019 Aug; 23(8):5154-5164. PubMed ID: 31207081
[TBL] [Abstract][Full Text] [Related]
5. MiR-503 inhibits hepatocellular carcinoma cell growth via inhibition of insulin-like growth factor 1 receptor.
Xiao Y; Tian Q; He J; Huang M; Yang C; Gong L
Onco Targets Ther; 2016; 9():3535-44. PubMed ID: 27366090
[TBL] [Abstract][Full Text] [Related]
6. microRNA-628 inhibits the proliferation of acute myeloid leukemia cells by directly targeting IGF-1R.
Chen L; Jiang X; Chen H; Han Q; Liu C; Sun M
Onco Targets Ther; 2019; 12():907-919. PubMed ID: 30774377
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA-1296 inhibits metastasis and epithelial-mesenchymal transition of hepatocellular carcinoma by targeting SRPK1-mediated PI3K/AKT pathway.
Xu Q; Liu X; Liu Z; Zhou Z; Wang Y; Tu J; Li L; Bao H; Yang L; Tu K
Mol Cancer; 2017 Jun; 16(1):103. PubMed ID: 28606154
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA-936 targets FGF2 to inhibit epithelial ovarian cancer aggressiveness by deactivating the PI3K/Akt pathway.
Li C; Yu S; Wu S; Ni Y; Pan Z
Onco Targets Ther; 2019; 12():5311-5322. PubMed ID: 31371979
[TBL] [Abstract][Full Text] [Related]
9. miR-342-3p suppresses hepatocellular carcinoma proliferation through inhibition of IGF-1R-mediated Warburg effect.
Liu W; Kang L; Han J; Wang Y; Shen C; Yan Z; Tai Y; Zhao C
Onco Targets Ther; 2018; 11():1643-1653. PubMed ID: 29615839
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA-155-5p promotes hepatocellular carcinoma progression by suppressing PTEN through the PI3K/Akt pathway.
Fu X; Wen H; Jing L; Yang Y; Wang W; Liang X; Nan K; Yao Y; Tian T
Cancer Sci; 2017 Apr; 108(4):620-631. PubMed ID: 28132399
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA-7 directly targets insulin-like growth factor 1 receptor to inhibit cellular growth and glucose metabolism in gliomas.
Wang B; Sun F; Dong N; Sun Z; Diao Y; Zheng C; Sun J; Yang Y; Jiang D
Diagn Pathol; 2014 Nov; 9():211. PubMed ID: 25394492
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA-519a promotes tumor growth by targeting PTEN/PI3K/AKT signaling in hepatocellular carcinoma.
Tu K; Liu Z; Yao B; Han S; Yang W
Int J Oncol; 2016 Mar; 48(3):965-74. PubMed ID: 26708293
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-761 targets FGFR1 to suppress the malignancy of osteosarcoma by deactivating PI3K/Akt pathway.
Lv Z; Ma J; Wang J; Lu J
Onco Targets Ther; 2019; 12():8501-8513. PubMed ID: 31686864
[TBL] [Abstract][Full Text] [Related]
14. MiR-448 suppresses cell proliferation and glycolysis of hepatocellular carcinoma through inhibiting IGF-1R expression.
Wang Y; Chen X; Yao N; Gong J; Cao Y; Su X; Feng X; Tao M
J Gastrointest Oncol; 2022 Feb; 13(1):355-367. PubMed ID: 35284123
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA-877 inhibits cell proliferation and invasion in non-small cell lung cancer by directly targeting IGF-1R.
Zhou G; Xie J; Gao Z; Yao W
Exp Ther Med; 2019 Aug; 18(2):1449-1457. PubMed ID: 31316632
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA-497 regulates cell proliferation in hepatocellular carcinoma.
Ding WZ; Ni QF; Lu YT; Kong LL; Yu JJ; Tan LW; Kong LB
Oncol Lett; 2016 Feb; 11(2):1081-1088. PubMed ID: 26893696
[TBL] [Abstract][Full Text] [Related]
17. miR-300 regulates the epithelial-mesenchymal transition and invasion of hepatocellular carcinoma by targeting the FAK/PI3K/AKT signaling pathway.
Wang R; Yu Z; Chen F; Xu H; Shen S; Chen W; Chen L; Su Q; Zhang L; Bi J; Zeng W; Li W; Huang X; Wang Q
Biomed Pharmacother; 2018 Jul; 103():1632-1642. PubMed ID: 29864952
[TBL] [Abstract][Full Text] [Related]
18. Long noncoding RNA TCL6 binds to miR-106a-5p to regulate hepatocellular carcinoma cells through PI3K/AKT signaling pathway.
Luo LH; Jin M; Wang LQ; Xu GJ; Lin ZY; Yu DD; Yang SL; Ran RZ; Wu G; Zhang T
J Cell Physiol; 2020 Sep; 235(9):6154-6166. PubMed ID: 32020591
[TBL] [Abstract][Full Text] [Related]
19. Effect of microRNA-135a on Cell Proliferation, Migration, Invasion, Apoptosis and Tumor Angiogenesis Through the IGF-1/PI3K/Akt Signaling Pathway in Non-Small Cell Lung Cancer.
Zhou Y; Li S; Li J; Wang D; Li Q
Cell Physiol Biochem; 2017; 42(4):1431-1446. PubMed ID: 28715819
[TBL] [Abstract][Full Text] [Related]
20. Long Non-Coding RNA NEAT1 Promoted Hepatocellular Carcinoma Cell Proliferation and Reduced Apoptosis Through the Regulation of Let-7b-IGF-1R Axis.
Liu Q; Shi H; Yang J; Jiang N
Onco Targets Ther; 2019; 12():10401-10413. PubMed ID: 31819522
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
